Drug intelligence / Profile preview

colloidal iodine

Development stage
Unknown
Lead developer
JCI Pharmaceutical
Modality
Small Molecules
Administration
Oral, Intravenous, Ophthalmic
01

Overview

**Colloidal iodine** is a nonproprietary name used for iodine-containing preparations marketed in multiple formulations, including oral solution, injection, and ophthalmic products, and also for some dietary supplement products containing elemental iodine or iodide. In the context provided, it most plausibly refers to small-molecule iodine preparations associated with JCI Colloidal Iodine Laboratory products rather than a single well-defined approved drug product. Pharmacologically, iodine acts as an iodine replacement source and, in topical or local-use contexts, can exert nonspecific antimicrobial and protein-denaturing effects, but the specific therapeutic indication, formulation standardization, and regulatory status of products sold as colloidal iodine are unclear and heterogeneous. The products described in the source context were identified as unapproved products not established by FDA as safe and effective, so this term should be treated as an ambiguous product name rather than a single clinically standardized medicine.

Other names
colloidal iodineiodineiodine solutionsodium iodide
02

Targets

TPO (Thyroid peroxidase)

Beyond the preview

Go deeper on colloidal iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colloidal iodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call